BioForce Nanosciences Holdings, Inc.
BFNH
$0.5279
$0.00450.86%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.06% | 7.69% | 7.39% | 0.44% | 0.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06% | 7.69% | 7.39% | 0.44% | 0.62% |
| Operating Income | -2.06% | -7.69% | -7.39% | -0.44% | -0.62% |
| Income Before Tax | -614.60% | -7.69% | -7.39% | -0.44% | -0.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -614.60% | -7.69% | -7.39% | -0.44% | -0.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -614.60% | -7.69% | -7.39% | -0.44% | -0.62% |
| EBIT | -2.06% | -7.69% | -7.39% | -0.44% | -0.62% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -544.44% | -7.69% | -7.69% | 0.00% | -2.27% |
| Normalized Basic EPS | 7.14% | -8.33% | -8.33% | 0.00% | 0.00% |
| EPS Diluted | -544.44% | -7.69% | -7.69% | 0.00% | -2.27% |
| Normalized Diluted EPS | 7.14% | -8.33% | -8.33% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 10.16% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 10.16% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |